Ayurveda formulation for COVID-19 preventio
Not Applicable
Completed
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Residents of the identified containment zones, marked by government of Himachal Pradesh for high risk of COVID 19
Willing to take study medication,
Provides written informed consent prior to initiation of study Procedures.
Exclusion Criteria
Persons already treated with study drug during the last 30 days;
Pregnant and lactating females and those who have a pregnancy plan.
Participants with any immunosuppressive medication or in an immune Compromised state or hematological disease.
Laboratory confirmed COVID-19 cases with or without symptoms.
Known allergy to the medication used in this trial.
Not willing to participate in the study.
Any other criteria, as per the investigator would jeopardize the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of COVID 19 positive cases as confirmed by hospital by standard investigation, real time polymerase chain reaction test among Ayurveda users.Timepoint: At baseline,1 week, 2 weeks, 3 weeks, 4 weeks
- Secondary Outcome Measures
Name Time Method 1)Incidence of severe COVID 19 positive cases (admitted in hospital and requiring ventilation and/or multi-organ failure as reported by hospital) among Ayurveda users. <br/ ><br>2)Incidence of mortality due to COVID 19 among Ayurveda users as compared to non-users. <br/ ><br>3)Incidence of any other ailment like cough, fever, sore throat etc. (as per questionnaire annexed) during this study. <br/ ><br>4)Change in appetite, bowel habit, sleep among the users <br/ ><br>Timepoint: 7th, 14th, 22nd and 30th day after first visit